AKAO News
Archived Headlines
- US IPO Recap: Varonis provides data security for enterprises and financial security for investors 03/03/14
- Antibacterial biotech Achaogen sets terms for $65 million IPO 02/25/14
- US IPO Recap: Care.com tends to a slow-starting IPO market 01/27/14
- Antibacterial biotech Achaogen files for a $75 million IPO 01/24/14
US IPO Recap: Castlight Health's 149% pop shows healthy tech demand
Castlight Health (CSLT) completed the fourth technology IPO of the year, and its 149% first day return brought the sector's average up to 95% for 2014. Castlight was also the ...read more
Biotechs post better returns this week before an IPO tech wave
Last week's two biotech IPOs - Aquinox Pharmaceuticals (AQXP) and Recro Pharma (REPH) - posted an average return of only 6% on their first day of trading on Friday. While Recro has continued to trade poorly, Aquinox has enjoyed a strong week, bringing its...read more
Achaogen prices upsized IPO at $12, the low end of the range
Achaogen, which is developing antibiotic treatments for multi-drug resistant infections, raised $72 million by offering 6.0 million shares at $12, at the low end of the $12 to $14 range. Insiders that previously indicated an intent to purchase up to 25% of the...read more
6 US IPOs planned for the week of Mar 10
The following IPOs are expected to price this week: Achaogen (AKAO), which is developing antibiotic treatments of multi-drug resistant infections, plans to raise $65...read more